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Abstract
 
Public health systems have relied on public health 
surveillance to plan health programs, and extensive sur-
veillance systems exist for health behaviors and chronic 
disease. Mental health has used a separate data collection 
system that emphasizes measurement of disease preva-
lence and health care use. In recent years, efforts to inte-
grate these systems have included adding chronic disease 
measures to the Collaborative Psychiatric Epidemiology 
Surveys and depression measures to the Behavioral Risk 
Factor Surveillance System; other data collection systems 
have been similarly enhanced. Ongoing challenges to inte-
gration include variations in interview protocols, use of dif-
ferent measures of behavior and disease, different interval 
reference periods, inclusion of substance abuse disorders, 
dichotomous vs continuous variables, and approaches to 
data collection. Future directions can address linking sur-
veillance efforts more closely to the needs of state programs, 
increasing child health measurements in surveys, and 
improving knowledge dissemination from survey analyses.
Introduction
 
This issue of Preventing Chronic Disease addresses 
the challenges of mental health and mental illness in 
the public health setting. According to the World Health 
Organization (WHO), mental illnesses account for more 
collective disability burden in developed countries than any 
other group of illnesses, including cancer and heart disease 
(1). Disability occurs because of both the effect of mental 
illness on emotions, thoughts, and daily function, and the 
link between mental illness and general health, especially 
chronic diseases (2). The Institute of Medicine’s (IOM’s) 
Quality Chasm series outlines action steps to improve the 
quality of all health care, including care for mental health 
and substance use conditions (2). The IOM notes that fail-
ure to provide mental health care also occurs in the United 
States’ public health system: “Despite evidence on risk fac-
tors associated with mental illnesses, or the risk factor that 
mental illness itself may pose to the development of chronic 
disease, effective public health interventions have not yet 
been adopted widely in practice” (2).
Definitions
 
Public health surveillance is “the ongoing, systematic 
collection, analysis, interpretation, and dissemination of 
data regarding a health-related event for use in public 
health action to reduce morbidity and mortality and to 
improve health” (3). Historically, surveillance focused on 
infectious disease, then broadened to other topics, includ-
ing chronic diseases. Now mental health and mental 
illness are increasingly recognized as domains in public 
health surveillance.
 
Mental health is a state of “successful performance of 
mental function, resulting in productive activities, fulfill-
ing relationships with other people, and the ability to 
adapt to change and to cope with adversity” (4). In 2004, 
WHO published its first report on mental health promo-
tion, conceptualizing mental health as not merely the 
absence of mental illness but the presence of “a state of 
well-being in which the individual realizes his or her own 
abilities, can cope with the normal stresses of life, can 
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work productively and fruitfully, and is able to make a 
contribution to his or her community” (1). Mental illness 
has been defined as a separate concept. Mental disorders 
are characterized by “alterations in thinking, mood, or 
behavior (or some combination thereof) associated with 
distress and/or impaired functioning” (4). The remainder 
of our discussion is focused on mental illness.
Impact of Mental Illness
 
An estimated 26% of Americans aged 18 years or older 
report having a diagnosable mental disorder in a given 
year (5). The estimated lifetime prevalence of mental 
disorders among the US adult population is 29% for anxi-
ety disorders, 25% for impulse-control disorders, 21% for 
mood disorders, 15% for substance use disorders, and 46% 
for any of these disorders (6). These disorders, especially 
depression, are among the leading global causes of life 
years lived with disability (1).
 
The incidence, course, and outcomes of chronic disease 
are influenced by mental illness, and the efficacy of inter-
ventions for mental illness are affected by the presence of 
chronic disease. The evidence is extensive for associations 
between mental illness and medical illnesses such as car-
diovascular disease, diabetes, obesity, asthma, epilepsy, 
and cancer (7,8). The association between mental illness 
and chronic disease is especially apparent among people 
with more serious and disabling mental illness, who are 
at risk of dying 25 years prematurely from cardiovascular 
and other chronic diseases (9). Research suggests that this 
association exists not only because of higher rates of smok-
ing and obesity or poor compliance with medical care, but 
also because of physiologic changes, including endothe-
lial inflammation, platelet stickiness, and changes in the 
epinephrine-norepinephrine axis and in cortisol metabo-
lism, as well as other metabolites mediated via central 
nervous system signaling (10).
Recent Developments in Mental Illness 
Surveillance
 
Traditionally, mental health and public health surveil-
lance have operated independent of each other. However, 
since the release of the first Surgeon General’s report on 
mental health in 1999, government agencies have begun 
building the infrastructure for establishing an ongoing 
system for mental health surveillance. Mental health 
measures are now included in established health surveil-
lance surveys such as the Centers for Disease Control and 
Prevention’s (CDC’s) National Health Interview Survey 
(NHIS), the National Health and Nutrition Examination 
Survey (NHANES), and the Behavioral Risk Factor 
Surveillance System (BRFSS); the Agency for Healthcare 
Research and Quality’s Medical Expenditure Panel 
Survey; the Substance Abuse and Mental Health Services 
Administration’s (SAMHSA’s) National Survey on Drug 
Use and Health (NSDUH); and in the National Science 
Foundation’s Panel Study of Income Dynamics (Table).
 
Epidemiologic surveys of mental illness, first published 
by analyzing army recruits in 1942, have been expanded 
to national populations with the Epidemiologic Catchment 
Area Study of 1980-1985, the National Comorbidity Survey 
of 1990-1992, and the National Comorbidity Survey 
Replication (NCS-R) of 2001-2003 (11). The Collaborative 
Psychiatric Epidemiology Surveys (CPES) (12) were ini-
tiated because of the need for contemporary data about 
the distributions, social and cultural correlates, and risk 
factors of mental disorders among the general population 
and in minority groups. CPES joins together 3 nationally 
representative surveys: the NCS-R, the National Survey 
of American Life, and the National Latino and Asian 
American Study, using an approach that facilitates com-
parisons across surveys and permits core modules of sur-
veys to be combined into a single data set for analysis. The 
CPES provides national-level data with sufficient power to 
investigate cultural and ethnic influences on mental and 
substance use disorders; mental health service use cor-
relates of interest; and chronic medical conditions such as 
arthritis, asthma, hypertension, heart disease, headache, 
allergies, back and neck pain, chronic pain, and diabetes. 
The data have been used to track the prevalence of mental 
health conditions for the Healthy People 2010 objectives 
and as benchmarks for rates of specific lifetime and previ-
ous 12-month mental disorders such as mood, anxiety, and 
impulse control disorders.
Measuring the Relationships Between 
Mental Illnesses, Health Risks, and Chronic 
Diseases 
Understanding the relationship between mental illness 
and chronic disease is vital to public health assessment 
and health care delivery. The primary surveillance tool 
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for assessing state-based estimates of health risk behav-
iors, chronic disease preventive services, and health care 
access is the BRFSS. The BRFSS is a random-digit–dialed 
survey of noninstitutionalized people aged 18 years or 
older, and systems are now in development for expanding 
its reach. These systems include call-back surveys, special 
population oversampling, and use of cell phone telephone 
numbers and paper surveys. BRFSS is unique in that it 
provides data at the state, county, and metropolitan and 
micropolitan statistical area levels.
 
Starting in 2006, state health departments, in col-
laboration with CDC and the Center for Mental Health 
Services at SAMHSA, implemented mental illness ques-
tions on the BRFSS. From 2006 to 2009, mental health 
modules have been included in the BRFSS in many 
states. The Patient Health Questionnaire 8 (PHQ-8), 
which screens for depressive symptoms, was adminis-
tered by 41 states and territories in 2006 and 16 states 
in 2008. The Kessler 6 (K-6) scale, which examines non-
specific psychological distress, was administered in 37 
states and territories in 2007 and continues implemen-
tation in 2009. Integrated analysis of mental health and 
other health issues has shown significant associations 
between mental illness and health risk behaviors (eg, 
smoking, obesity, physical inactivity), chronic disease 
(eg, arthritis, diabetes, cardiovascular disease, asthma), 
and lower levels of preventive care. The BRFSS is among 
the first surveillance systems that allow population-
based state and local estimates for mental and physical 
health, which are critical for policy and programs at the 
state and community levels.
 
Progress has been made with regard to the inclusion of 
health topics in mental health surveillance at the state 
level (eg, inclusion of selected BRFSS health questions in 
the Mental Health Statistics Improvement Program con-
sumer satisfaction survey in several states). This improved 
surveillance indicates that people with serious mental ill-
ness (SMI), defined as having a DSM-IV (Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition) 
mental disorder that resulted in functional impairment, 
who also have poor physical health, are more likely to have 
poor functional outcomes and lower levels of satisfaction 
with their mental health care (13). States can now also 
analyze their Medicaid services data to examine the effect 
of co-occurring mental illness, substance use disorders, 
and chronic medical conditions on utilization and out-
comes for chronic disease and behavioral disorders.
 Data and instrumentation from the resources listed in 
the Table are available online for secondary analysis or 
public use. With the exception of the current (2007 and 
beyond) NHANES, each of the survey instruments listed 
contains the K-6 nonspecific psychological distress scale, 
which is also included in the CPES benchmark studies. 
This “common currency” approach to instrumentation 
facilitates general comparisons among studies; however, 
variations among survey instruments and methods must 
be considered when interpreting data from different 
sources.
Variations Among Surveys
 
The ways different surveys define and measure men-
tal illnesses often vary. One approach uses interview 
protocols that ask various symptom, duration, and fre-
quency questions for specific mental disorders, on the 
basis of classification systems such as the DSM or the 
International Classification of Diseases (ICD) systems. 
For example, depression may be measured by using 
the WHO Composite International Diagnostic Interview 
(CIDI) depression module, an instrument designed for use 
in general population surveys, or the PHQ, an instrument 
designed for use in clinical settings but also used in some 
health surveys. The WHO CIDI approach provides consid-
erable detail at the national level about specific disorders 
but requires extensive resources to complete. The PHQ-2, 
PHQ-8, and PHQ-9, validated measures for depressive 
symptoms in wide use in clinical care, are sufficiently 
brief to be included in population-based surveys and public 
health awareness campaigns.
 
Another approach is to use different mental health 
measures to assess “any mental disorder” (as opposed to 
a specific disorder) by using nonspecific measures of psy-
chological function. These brief scales, commonly found 
in large, population-based surveys, can be used to iden-
tify subpopulations with a high likelihood of having any 
mental illness. For example, the K-6 scale was originally 
developed for use in the NHIS as a measure of nonspecific 
psychological distress (a proxy for poor mental health) 
during the past 30 days. SAMHSA then supported a pilot 
study to determine whether a version of the K-6 that 
assessed distress in the past year could identify SMI cases 
in the general population (14). In 2008, SAMHSA added 
impairment and suicide-assessment scales to the NSDUH 
mental health module and launched a full-scale study 
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to calibrate it to a clinical (psychiatric) evaluation in a 
nationally representative sample. Results from this study 
will be used to estimate the prevalence of SMI at the state 
and national levels.
 
Another distinction is the reference period, which differs 
among data collection systems. Serious psychological dis-
tress, which is defined as having a K-6 score of 13 or high-
er during 1 month in the past 12 months, is determined in 
the NSDUH with the use of a past-year reference period 
and past-30-day reference period (since 2008). NHIS and 
BRFSS use a past-30-day reference period only. Different 
reference periods (current, past year, lifetime) are also 
found in disorder-specific measures (such as depression), 
depending on the purpose of the study. The reference 
period used has a substantial effect on the prevalence rate 
yielded, not only because the estimates may be subject to 
recall bias but also because longer reference periods may 
result in a larger number of affirmative responses.
 
Other approaches to assessing mental illness have 
depended on the presence of functional impairments and 
still others on whether there is a history of treatment. 
Surveys vary as to the inclusion or exclusion of substance 
use disorders and cognitive disturbances, such as demen-
tia, under a broader umbrella of mental disorders. These 
variations in mental illness definitions have provided data 
on overlapping but nonidentical populations.
 
Another issue in mental health surveillance is whether 
specific or nonspecific disorders and associated impair-
ments are measured continuously or dichotomously. 
Dichotomous measures indicate whether a specific thresh-
old or cutpoint was reached. In contrast, using a con-
tinuous measure may allow mild, moderate, and severe 
levels of disorder to be identified. Studies have shown 
that untreated minor depression or residual subthreshold 
depressive symptoms after treatment are often associated 
with disability and poor psychosocial functioning and a 
potentially more severe, relapsing, and chronic course that 
requires additional treatment (15).
 
The method of data collection may also affect com-
parability. For example, while most data are collected 
via computer-assisted interviews, some surveys are self-
administered (eg, NSDUH, parts of NHANES are read to 
respondents via audio-computer technology), and others 
are administered by an interviewer in the home or on 
the telephone. These differences affect survey responses, 
particularly for mental health questions and sensitive 
items such as illegal or embarrassing behavior (16).
Future Directions
 
We have focused on existing efforts in mental illness sur-
veillance but recognize the value of monitoring the preva-
lence and correlates associated with psychological well-
being, as discussed by Manderscheid et al in this issue 
(17). Future public health surveillance systems should 
incorporate measures of positive psychological function as 
both a protective factor against poor health outcomes and 
a mental health indicator of interest in its own right.
 
Surveillance efforts can be more meaningfully linked to 
state and local health policy and program development 
efforts. Ongoing, multiyear inclusion of mental health 
modules in state and local level surveys may permit state 
epidemiologists to monitor the effects of community health 
partner efforts. We must also develop culturally meaning-
ful surveillance of mental health and mental illness in 
specific populations, such as ethnic minorities, veterans, 
parents, caregivers, and people who are disabled.
 
A lifespan approach to mental health and mental ill-
ness will facilitate a better understanding of the natural 
course of mental illness and its effect on overall health. 
Most surveys focus on adults and include few measures of 
child health. Studies of mental health and mental illness 
in younger populations are relevant to the development 
of prevention strategies applied at the earlier stages of 
development.
 
Evidence-based care is the gold standard for health care 
providers, but we lack a systematic approach to moni-
tor effectiveness of treatment for mental disorders. Data 
on medications, unmet needs for mental health services, 
and outcomes such as employment, housing stability, and 
consumer satisfaction are available (18,19). However, 
these measures leave gaps in our understanding of the 
effect of specific types of treatment in different popula-
tions or the relevance of factors such as duration, location, 
or type of provider. The role of nonprofessional support 
systems, such as community, spiritual, family, or peer 
networks, is not fully explored. Effectiveness of treatment 
has often been measured as if people only have a single 
mental illness; however, people with these illnesses often 
have complex comorbidities, including substance abuse, 
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cognitive impairments, and chronic medical conditions. 
These dimensions should be addressed as well in evaluat-
ing efficacy of treatment systems.
 
Knowledge dissemination is a critical aspect of surveil-
lance, but natural lines of communication in public health 
and in mental health have generally been separate; 
information has typically been disseminated from CDC 
to state and local public health infrastructure and health 
care providers, and from SAMHSA to state mental health 
authorities, mental health advocacy organizations, and 
mental health providers. Systems should be developed so 
information from an integrated mental health and physi-
cal health surveillance system can be directed broadly to 
specialty mental health and substance abuse providers, 
public health systems, community health providers, and 
community health promotion programs.
Conclusion
 
In the past decade we have moved from a tradition of 
separate mental health and public health surveillance 
efforts to an increasingly integrated approach. Agencies 
in the US Department of Health and Human Services are 
collaborating to create new systems and expand existing 
ones. These systems monitor mental illness by incorporat-
ing common mental health measures in ongoing federal 
surveys, conducting large psychiatric epidemiology bench-
mark surveys, and facilitating health risk factor surveil-
lance surveys that include mental health variables at the 
state and local levels. Substantive elements of a mental 
health surveillance system exist today, although there is 
work to be done to make an integrated approach standard 
practice.
 
Surveillance has focused largely on established disease 
or symptoms, but collection of additional data on resil-
ience, coping skills, protective factors, and aspects of posi-
tive mental health are considerations in devising strate-
gies for disease prevention and mental health promotion. 
Maintaining focus on the overall health of our population 
will be critical in the next decades, as will leaving behind 
the commonly accepted divide between mental and physi-
cal illnesses, “despite the fact that both exist within indi-
viduals in an exquisitely integrated fashion” (20). An opti-
mal surveillance system will examine interactions among 
biological, social, psychological, and environmental factors 
to support health promotion, intervention programs, and 
both mental illness and chronic disease prevention.
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Table
Table. United States Surveys That Contain Publicly Available Mental Health Data, 2009
Survey Type Year Representation
Age 
Range
Sample 
Size Link
Psychiatric epidemiology studies
National Comorbidity Survey Replication 2001-200 National ≥18 y 9,282 www.hcp.med.harvard.edu/ncs/
National Survey of American Life (black 
Americans)
2001-200 National ≥18 y 6,199 www.icpsr.umich.edu/CPES/
National Latino and Asian American 
Study
2001-200 National ≥18 y 4,864 www.multiculturalmentalhealth.org/nlaas.asp
Ongoing health surveys containing mental health questionnaires
Behavioral Risk Factor Surveillance 
System
Ongoing State ≥18 y 0,000/y www.cdc.gov/BRFSS/
National Survey on Drug Use and 
Health
Ongoing National and state ≥12 y 67,000/y http://oas.samhsa.gov/nsduh.htm  
National Health Interview Survey Ongoing National ≥18 y 2,000/y www.cdc.gov/nchs/nhis.htm
National Health and Nutrition 
Examination Survey
Ongoing National ≥12 y ,000/y www.cdc.gov/nchs/nhanes.htm
Medical Expenditure Panel Survey Ongoing National All ages 2,000/y www.meps.ahrq.gov/mepsweb/
Panel Study of Income Dynamics Ongoing (longi-
tudinal)
National All ages 7,000 fam-
ilies (total 
panel)
http://psidonline.isr.umich.edu/Guide/
